Nueclear Web Banner
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
ORIGINAL ARTICLE
Ahead of Print

CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?


1 Department of Hematology, Medical Faculty, Trakya University, Edirne, Turkey
2 Department of Medical Genetics, Medical Faculty, Trakya University, Edirne, Turkey
3 Health Services Vocational College, Trakya University, Edirne, Turkey
4 Department of Rheumatology, Medical Faculty, Trakya University, Edirne, Turkey

Correspondence Address:
Gulsum Emel Pamuk,
Eski Yildiz Cad, Park Apt. No. 22 Daire: 18, 34349, Besiktas, Istanbul
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Objective: We studied CXCL12-related rs18011157 polymorphism in non-Hodgkin lymphoma (NHL) patients. We also determined the effect of this polymorphism on clinical features and outcome of NHL. Methods: We included 90 NHL patients (54 males, 36 females) and 88 healthy controls (54 males, 34 females). CXCL12-related rs18011157 polymorphism was determined by polymerase chain reaction. Results: rs18011157 polymorphism was significantly more frequent in NHL patients with GA genotype than in healthy controls (37.8% vs. 20.5%, P = 0.011). The frequency of patients with initially high lactate dehydrogenase (LDH) level (65.8% vs. 38.5%) and extranodal involvement (61.1% vs. 43.8%) was significantly higher in the GA plus AA genotype groups when considered altogether (P = 0.01 and 0.09). Poor prognostic factors in univariate analysis were the presence of B symptoms, initially high International Prognostic Index (IPI), splenomegaly, nonresponse to first-line therapy, the presence of early relapse, and carrying A allele (GA plus AA genotypes). The independent prognostic factors in multivariate analysis were only early relapse and an initially high IPI score. Discussion: CXCL12 rs1801157 polymorphism which was found to be associated with extranodal involvement and increased LDH in NHL might be a marker of poor prognosis in patients with GA and AA genotypes. Conclusions: CXCL12-related rs18011517 polymorphism was more frequent in NHL patients: it might be associated with NHL pathogenesis and outcome.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Pamuk GE
    -  Tozkır H
    -  Uyanık MS
    -  Gurkan H
    -  Duymaz J
    -  Pamuk ON
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed202    
    PDF Downloaded12    

Recommend this journal